Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2009 - 2026)

Vertex Pharmaceuticals' Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$40.3 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 232.13% year-over-year to -$40.3 million; the TTM figure through Mar 2026 stood at $20.1 million (up 474.29% YoY), while the FY2025 annual figure was $90.9 million, up 313.38% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at -$40.3 million, down from $7.3 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $57.2 million in Q2 2025, with the low at -$47.3 million in Q4 2024.
• The 5-year median for Exchange Rate Effect is -$2.5 million (2024), against an average of $335294.1.
• The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect plunged 747.5% in 2022, then soared 2388.0% in 2025.
• Vertex Pharmaceuticals' Exchange Rate Effect stood at $40.8 million in 2022, then sank by 32.84% to $27.4 million in 2023, then plunged by 272.63% to -$47.3 million in 2024, then soared by 115.43% to $7.3 million in 2025, then plunged by 652.05% to -$40.3 million in 2026.
• Business Quant data shows VRTX's Exchange Rate Effect at -$40.3 million in Q1 2026, $7.3 million in Q4 2025, and -$4.1 million in Q3 2025.